Juliet Namugambe Sanyu
ID:
|
Quality of Antimalarials and Antibiotics in Private Medicine Outlets in Bugisu Region, Eastern Uganda
REFNo: HS2667ES
6. To assess perceptions of medicine sellers on quality of antimicrobials and how that influences their prescribing decisions in private medicine outlets in Bugisu, Eastern Uganda. ,5. To describe the methods used to identify poor-quality antimicrobials and the reporting systems used by private medicine outlets in Bugisu sub-region, Eastern Uganda.,4. To assess the conditions in premises associated with SF antimalarials and antibiotics in private rural and urban medicine outlets in Bugisu region, Eastern Uganda.,3. To assess the knowledge and practices of outlet owners associated with SF antimalarials and antibiotics in private rural and urban medicine outlets in Bugisu region, Eastern Uganda.,2. To assess the prevalence of substandard and falsified (SF) antimalarials and antibiotics offered for sale in the authorized and unauthorized private medicine outlets in Bugisu region, Eastern Uganda.,1. To assess the prevalence of substandard and falsified (SF) antimalarials and antibiotics offered in sale in private rural and urban medicine outlets in Bugisu region, Eastern Uganda,This study aims to measure the prevalence of substandard and falsified antimalarials and antibiotics in private medicine outlets of Bugisu sub-region in Eastern Uganda and explore the characteristics of rural, urban, authorised and unauthorised outlets and their influence on observed quality, as well as the medicine sellers perception on quality of medicines in the region.,
|
Uganda |
2023-02-06 16:50:57 |
2026-02-06 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
.jpg)
|
Grace Mulyowa Kitunzi
ID: UNCST-2022-R009761
|
An Image Diagnostic tool for supporting clinicians managing Dermatitis Cruris Pustulosa et Atrophicans among Patients Presenting to Mbarara and Kabale Regional Referral Hospitals
REFNo: SIR186ES
• To improve diagnosis of DCPA through a machine learning model trained from locally obtained images.,
|
Uganda |
2023-02-06 16:44:23 |
2026-02-06 |
Engineering and Technology |
Non-Clinical Trial |
Non-degree Award |
|
Kevin Arbuckle
ID:
|
Using community engagement to improve snakebite prevention measures in rural Uganda
REFNo: HS2326ES
The project aims to improve awareness and implementation of prevention measures against snakebite envenoming in rural communities in Uganda. In doing so our ultimate aim is to reduce the burden of snakebite envenoming in these high risk areas, using our local connections and community-integration approach to ensure the project continues to deliver this aim long after the end of the funding period.
We will achieve our aim via the following specific objectives:-
- Gain an understanding of current community knowledge and attitudes surrounding snakes and snakebite via interviews and surveys.
- Use the information from the first objective to prepare appropriate materials for co-creation workshops with the local community to promote awareness of local snakes and snakebite risk, implementation of prevention strategies, and discussion of appropriate responses in the event of a bite, all with attention given to targeted and specific solutions to local challenges and context.
- Donation of appropriate resources to assist local communities in reducing the risk of snakebite, such as appropriate footwear to prevent accidental bites on exposed feet and handling equipment to enable trained members of the community to move snakes away from high-risk locations such as school premises and homes (see final objective).
- Implement a 'train-the-trainer' programme to train the co-applicant in safe removal of snakes from premises and to enable him to take advantage of his teacher-training to pass these skills onto other willing members of the community. This will ultimately lead to a sustained network of members of the local community who can maintain risk reduction in the longer term.
|
UK |
2023-02-06 16:42:29 |
2026-02-06 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Noella Okalany Akwi Regina
ID: UNCST-2022-R011085
|
Congenital Cytomegalovirus Infection in Eastern Uganda
REFNo: HS2668ES
To determine the short-term neurodevelopmental outcomes and hearing impairment associated with congenital cytomegalovirus among infants in Eastern Uganda.,To determine the incidence of, and risk factors for postnatally acquired cytomegalovirus among infants in Eastern Uganda.,To describe the factors associated with congenital cytomegalovirus infection in neonates in Eastern Uganda.,To determine the prevalence of congenital cytomegalovirus infection among neonates in Eastern Uganda,To investigate the burden of congenital cytomegalovirus and its outcomes among infants in Eastern Uganda.,
|
Uganda |
2023-02-06 16:21:08 |
2026-02-06 |
Medical and Health Sciences |
Clinical Trial |
Degree Award |
|
Adeodata Rukyalekere Kekitiinwa
ID: UNCST-2019-R000799
|
IMPAACT 2028: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV; DAIDS Study ID #38693
REFNo: HS2417ES
To characterize the long-term clinical, immunologic, and Virologic profiles of children who received early treatment for perinatally-acquired HIV
|
Uganda |
2023-02-06 16:17:13 |
2026-02-06 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Kathy Burgoine
ID: UNCST-2022-R011521
|
Impact of prophylactic Continuous Positive Airway Pressure in the Delivery Room (DR-CPAP) on neonates <1500g in a low-resource setting: A feasibility trial
REFNo: HS2605ES
- To determine the acceptability of DR-CPAP to healthcare workers in a low-resource setting
- To determine the post-intervention acceptability of using a two-stage consent process in neonatal emergencies in the delivery room in this setting
- To evaluate the feasibility of a third-party allocation process for randomisation by determining the time to randomization
- To evaluate feasibility of initiating DR-CPAP in a low-resource setting in infants with birthweight 800-1500g within 15 minutes of delivery
- To determine the safety of initiating DR-CPAP in a low-resource setting
- To estimate the sample size to be used for future evaluation in the full trial
- To assess the feasibility of secondary outcome measures to be used in the full trial
|
UK |
2023-02-02 12:18:23 |
2026-02-02 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Rachel Kawuma Mary Kagawa
ID: UNCST-2022-R009107
|
Understanding digitally driven risk networks to inform user-centric target product profiles (TPP)
for next-generation HIV vaccines (DigiTaPP Study)
REFNo: SS1519ES
Objective 1: To understand HIV prevention product development pipeline and potential vaccine attributes through scientific consultations with vaccine experts and product developers
Sub-objectives:
1. To understand current status of HIV vaccine development pipeline and potential HIV vaccine candidates along with potential product attributes;
2. To explore how communities are being involved in the development process, especially whether the preferences of potential end-users are being considered in TPP development.
Objective 2: To understand the nature and characteristics of HIV risk networks (or sexual networks of target populations at risk for HIV), across digital and physical spaces to inform strategies for engaging all potential end-users
Sub-objectives:
1. To identify the nature and types of physical and virtual platforms used by relevant target populations, explore their stated reasons for using them, and their interconnections;
2. To explore the differences in risk behaviours, current prevention practices and preference for prevention products (including vaccines) among the end-users from physical and digital networks.
Objective 3: To understand preferences of potential end-users (from digital and physical networks) through elicitation research towards informing HIV vaccine target product profile
Sub-objectives:
1. To understand end-users’ preferences for product characteristics and delivery sites;
2. To understand perceived benefit, perceived burden and self-efficacy that may influence product attribute preferences and delivery options;
3. To understand interpersonal and social influences that may influence product attribute preferences and delivery options.
|
Uganda |
2023-02-02 11:58:48 |
2026-02-02 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Peter Kisaakye
ID:
|
Measuring the incidence of abortion and the quality of postabortion care in refugee settings in Uganda
REFNo: SS1589ES
1. To measure the incidence of abortion in refugee settings in Uganda
2. To determine the severity of abortion-related complications in refugee settings in Uganda
3. To assess the capacity of the health system to offer post-abortion care to people living in refugee settings in Uganda
|
Uganda |
2023-02-01 12:38:01 |
2026-02-01 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
JANE AMUGE
ID:
|
Implementing the Cooperative Resilience Measurement Index (CRMI) for Cooperatives in Uganda
REFNo: SS1592ES
1. Build the capacity of the cooperatives to establish prioritisation and ownership of the resilience investment.
2. Interrogate the value proposition of the CMRI to enhance cooperative sustainable resilience and competitiveness in Uganda.
3. To test the value proposition of the Coop Profiler to ensure adoption of the CMRI amongst cooperatives in Uganda
4. Publish a paper on the resilience capacity of agribusiness cooperatives in Uganda with policy recommendations
|
Uganda |
2023-02-01 12:17:53 |
2026-02-01 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Margaret Lubwama
ID: UNCST-2019-R000636
|
Gastrointestinal colonization with drug resistant bacteria in Ugandan patients with cancer and HIV
REFNo: HS2437ES
The overall purpose of the study is to determine the prevalence of ESBL and CRE gastrointestinal colonization in patients with newly diagnosed cancer at the time of chemotherapy initiation and determine how colonization changes over the first month after chemotherapy is initiated.
The aims of the study are;
1. To define the association between HIV status and prevalence of gastrointestinal colonization with multidrug resistant organisms (MDROs) among patients with cancer in Uganda.
2. To assess the factors associated with incident MDRO colonization in the first 30-days after initiation of chemotherapy.
3. To investigate whether gastrointestinal colonization with an MDRO is associated with an increased risk of developing a bacterial bloodstream infection with that organism.
|
Uganda |
2023-01-31 12:02:29 |
2026-01-31 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|